rs1297294136
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PM4_SupportingBP6BS2
The NM_000489.6(ATRX):c.2247_2249delTTC(p.Ser750del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000215 in 1,209,048 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000489.6 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- alpha thalassemia-X-linked intellectual disability syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- ATR-X-related syndromeInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability-hypotonic facies syndrome, X-linked, 1Inheritance: XL Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.2247_2249delTTC | p.Ser750del | disruptive_inframe_deletion | Exon 9 of 35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000359 AC: 4AN: 111351Hom.: 0 Cov.: 22 show subpopulations
GnomAD2 exomes AF: 0.0000164 AC: 3AN: 182605 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000200 AC: 22AN: 1097697Hom.: 0 AF XY: 0.0000165 AC XY: 6AN XY: 363127 show subpopulations
GnomAD4 genome AF: 0.0000359 AC: 4AN: 111351Hom.: 0 Cov.: 22 AF XY: 0.0000298 AC XY: 1AN XY: 33551 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Alpha thalassemia-X-linked intellectual disability syndrome Uncertain:1
This variant, c.2247_2249del, results in the deletion of 1 amino acid(s) of the ATRX protein (p.Ser750del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.003%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ATRX-related conditions. ClinVar contains an entry for this variant (Variation ID: 533625). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at